GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » COGS-to-Revenue

Synthetic MR AB (XSAT:SYNT) COGS-to-Revenue : -0.09 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB COGS-to-Revenue?

Synthetic MR AB's Cost of Goods Sold for the three months ended in Mar. 2024 was kr-1.69 Mil. Its Revenue for the three months ended in Mar. 2024 was kr17.78 Mil.

Synthetic MR AB's COGS to Revenue for the three months ended in Mar. 2024 was -0.09.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Synthetic MR AB's Gross Margin % for the three months ended in Mar. 2024 was 109.49%.


Synthetic MR AB COGS-to-Revenue Historical Data

The historical data trend for Synthetic MR AB's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB COGS-to-Revenue Chart

Synthetic MR AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.06 -0.07 -0.07 -0.08 -0.06

Synthetic MR AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.07 -0.06 -0.04 -0.09

Synthetic MR AB COGS-to-Revenue Calculation

Synthetic MR AB's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=-5.159 / 89.213
=-0.06

Synthetic MR AB's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=-1.687 / 17.784
=-0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synthetic MR AB  (XSAT:SYNT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Synthetic MR AB's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - -1.687 / 17.784
=109.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Synthetic MR AB COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthetic MR AB (XSAT:SYNT) Business Description

Traded in Other Exchanges
N/A
Address
Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (XSAT:SYNT) Headlines

From GuruFocus

Syntel Joins Google Cloud Partner Program

By Marketwired Marketwired 03-26-2018

Syntel enters definitive agreement to be acquired by Atos S.E.

By Marketwired Marketwired 07-22-2018

Third Avenue Management Comments on Syntel

By Holly LaFon 07-02-2013

Insiders Are Investing in Syntel

By Kyle Ferguson Kyle Ferguson 04-27-2017

Syntel Inc. (SYNT) CFO & CISO Arvind Godbole sells 2,175 Shares

By GuruFocus Research GuruFocus Editor 12-09-2010

Syntel Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-08-2010

A Solid Pick at a Fair Price

By Jae Jun Jae Jun 03-31-2015

Syntel Inc. (SYNT) CEO and President Prashant Ranade sells 3,000 Shares

By GuruFocus Research GuruFocus Editor 12-17-2010